Warning: The NCBI web site requires JavaScript to function. more...
What we still don't know about AIDS.
Robertson M.
J Biol. 2009;8(10):87. Epub . No abstract available.
Related citations
The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
Priceputu E, Rodrigue I, Chrobak P, Poudrier J, Mak TW, Hanna Z, Hu C, Kay DG, Jolicoeur P.
J Virol. 2005 May;79(10):6377-91.
Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: intravaginal and oral deposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS.
Joag SV, Adany I, Li Z, Foresman L, Pinson DM, Wang C, Stephens EB, Raghavan R, Narayan O.
J Virol. 1997 May;71(5):4016-23.
Reservoirs dog AIDS therapy.
Smaglik P.
Nature. 2000 May 18;405(6784):270-2. No abstract available.
Building a small-animal model for AIDS, block by block.
Cohen J.
Science. 2001 Aug 10;293(5532):1034-6. No abstract available.
A new way to resist AIDS?
Kaiser J.
Science. 1997 Feb 28;275(5304):1258. No abstract available.
CD4 T helper lymphocytes and antigen presenting cells in the physiopathology of AIDS.
Hosmalin A, Autran B, McIlroy D, Grassi F, Samri A, Debré P.
Mem Inst Oswaldo Cruz. 1998 May-Jun;93(3):405-6. No abstract available.
Toward an understanding of the correlates of protective immunity to HIV infection.
Haynes BF, Pantaleo G, Fauci AS.
Science. 1996 Jan 19;271(5247):324-8. Review.
HIV replication.
Kingman S.
Mol Med Today. 1995 Apr;1(1):2. No abstract available.
[Linking Nef with the immunological and virological determinants of AIDS].
Gómez-Icazbalceta G, Larralde C.
Rev Invest Clin. 2009 May-Jun;61(3):243-51. Spanish.
Disturbed CD4+ T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors.
Sawada S, Gowrishankar K, Kitamura R, Suzuki M, Suzuki G, Tahara S, Koito A.
J Exp Med. 1998 May 4;187(9):1439-49.
Animal models for the study of human immunodeficiency virus infections.
Letvin NL.
Curr Opin Immunol. 1992 Aug;4(4):481-5. Review.
HIV's other immune-system targets: macrophages.
Balter M.
Science. 1996 Nov 29;274(5292):1464-5. No abstract available.
[HIV without AIDS but no AIDS without HIV].
Soriano V, González-Lahoz J.
Med Clin (Barc). 1995 Jul 1;105(5):172-3. Review. Spanish. No abstract available.
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.
Rose NF, Marx PA, Luckay A, Nixon DF, Moretto WJ, Donahoe SM, Montefiori D, Roberts A, Buonocore L, Rose JK.
Cell. 2001 Sep 7;106(5):539-49.
Questions about HIV causing AIDS? Viral load and T-cell (CD4) counts: why they really matter.
[No authors listed]
AIDS Treat News. 2001 May 11;(364):7-8. No abstract available.
Modeling HIV concentration during acute AIDS infection.
Wilson SE, Habeshaw JA, Oxford JS.
Science. 1996 Jun 28;272(5270):1960-2. No abstract available.
Immunology in AIDS in 1990.
Sela M.
AIDS. 1990;4 Suppl 1:S9-14. Review. No abstract available.
AIDS research. Cytokines move from the margins into the spotlight.
Science. 1995 Apr 14;268(5208):205-6. No abstract available.
Deletion of nef slows but does not prevent CD4-positive T-cell depletion in human immunodeficiency virus type 1-infected human-PBL-SCID mice.
Gulizia RJ, Collman RG, Levy JA, Trono D, Mosier DE.
J Virol. 1997 May;71(5):4161-4.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on